Home
About
FAQ
History (13)
HDAC expression and activity is upregulated in diseased lupus-prone mice.
Adverse cutaneous effects of neratinib.
New targets of therapy in T-cell lymphomas.
An individually-tailored multifactorial intervention program for older fallers in a middle-income developing country: Malaysian Falls Assessment and Intervention Trial (MyFAIT).
Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (595)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Thomas A. Arcury PhD
Wake Forest School of Medicine
Why?
Mark A. Hall JD
Wake Forest School of Medicine
Why?
Steven R. Feldman MD, PhD
Wake Forest School of Medicine
Why?
Scott D. Rhodes PhD
Wake Forest School of Medicine
Why?
Leigh E. Boulware MD, MPH
Wake Forest School of Medicine
Why?
Justin B. Moore PhD, MS
Wake Forest School of Medicine
Why?
Amresh D. Hanchate PhD
Wake Forest School of Medicine
Why?
Yhenneko Taylor PhD
Why?
Kathryn E. Weaver PhD
Wake Forest School of Medicine
Why?
Sarah A. Birken PhD, MSPH
Wake Forest School of Medicine
Why?
Sally A. Shumaker PhD
Wake Forest School of Medicine
Why?
Lindsay A. Thompson
Wake Forest School of Medicine
Why?
Gary E. Rosenthal MD, FACP
Wake Forest School of Medicine
Why?
Mark A. Espeland PhD
Wake Forest School of Medicine
Why?
Nancy E. Avis PhD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 40
Next
Prev
Search Criteria
Health
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions